Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biofilm extracellular polymeric substance matrix components are high-molecular-weight biopolymers—primarily polysaccharides, proteins, nucleic acids (notably extracellular DNA), and lipids—synthesized and secreted by microorganisms during biofilm formation[1][3]. These substances create a hydrated and highly structured extracellular matrix that embeds microbial communities, providing cohesion, mechanical stability, and protection from environmental stresses, including desiccation, antimicrobial agents, and predation. The matrix also modulates nutrient diffusion, facilitates intercellular communication, and serves as a primary determinant of biofilm phenotype and resistance to treatment. EPS composition is heterogeneous and dynamic, varying by organism, developmental stage, and environment, which presents both scientific and therapeutic challenges[2][3][4][5]. Note: EPS is not a classic "receptor," "enzyme," or single defined protein—rather, it is a structural target representing a complex, dynamic mixture of biopolymers fundamental for biofilm integrity. This makes it a collective and emerging target for anti-biofilm strategies, especially in infectious disease and device-associated biofilm contexts[1][3][4].
Enzymatic degradation of matrix components (e.g., DNase digests extracellular DNA; dispersin B degrades β-1,6-N-acetyl-D-glucosamine polysaccharides); Matrix disruption to increase antibiotic penetration; Chelation of metal ions to destabilize matrix cross-linking; Surfactant-mediated detachment of cells
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biofilm extracellular polymeric substance matrix component (EPS).